SightfileU.S. market data from official filings

Companies › XNCR

XENCOR INC COM (XNCR)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001326732 · EDGAR filings · Updated 2026-07-08

XENCOR INC COM (XNCR) has reported institutional ownership of 113.9%, with 203 institutional managers holding positions valued at $1.02B per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02).

Institutional ownership
113.9%
Institutional managers
203
Reported 13F value
$1.02B
Insider activity
35 trans.
−$3.69M net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, XENCOR INC COM has 203 institutional holders and institutional ownership of 113.9%.

Insider activity

Insiders reported 35 transactions (0 buys, 19 sells) across 12 reporting insiders, with a net reported value of −$3.69M.

Data flags from SEC filings

Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2025-02-13 (recurring since 2025-02-13) — source filing. The authoritative details are those stated in the filing itself.

Related companies

RECURSION PHARMACEUTICALS IN (RXRX) · CAPRICOR THERAPEUTICS INC (CAPR) · CORVUS PHARMACEUTICALS INC (CRVS) · ARDELYX INC (ARDX) · SMITH & NEPHEW PLC (SNN) · STAAR SURGICAL CO (STAA)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-08.